Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Compound I D1 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104945363B reveals a scalable synthesis for SGLT2 inhibitor intermediates, offering cost-effective alternatives to conventional dapagliflozin-based routes for pharmaceutical supply chains.